Question 1

What is Insilico Medicine?

Accepted Answer

Insilico Medicine is a Entity.

Question 2

How often does Insilico Medicine appear in global news?

Accepted Answer

Tracked across 7 news events drawn from 354 articles.

Question 3

When was Insilico Medicine first tracked by Ergen?

Accepted Answer

First tracked on Apr 02, 2026.

Question 4

When was Insilico Medicine last mentioned in news?

Accepted Answer

Last active on Aug 10, 2026.

Question 5

What is Insilico Medicine's current news sentiment?

Accepted Answer

Aggregate sentiment score: 39 on a -100 to +100 scale (negative = critical coverage, positive = favorable coverage).

Question 6

How prominent is Insilico Medicine in global news coverage?

Accepted Answer

Attention score of 6, derived from article volume and coverage intensity across 7 events.

Question 7

What is the most recent event involving Insilico Medicine?

Accepted Answer

Insilico Medicine, Takeda AI Drug Discovery (Jul 02, 2026, 8 articles).

Question 8

How did the "Insilico Medicine, Takeda AI Drug Discovery" event impact Insilico Medicine?

Accepted Answer

Insilico Medicine has entered into a strategic collaboration with Takeda, leveraging its Pharma.AI platform for drug discovery. This agreement could bring Insilico Medicine up to $600 million in milestone payments and royalties, significantly boosting its financial outlook and validating its AI-driven approach.

Question 9

How did the "Insilico-CMS second CNS collaboration" event impact Insilico Medicine?

Accepted Answer

Insilico deepens its partnership with CMS, securing up to 1.2 billion RMB in milestones and royalties, reinforcing its AI platform's productivity and out-licensing strategy.

Question 10

How did the "Insilico gets FDA Fast Track for ISM6331" event impact Insilico Medicine?

Accepted Answer

Insilico received its first FDA Fast Track Designation for ISM6331, validating its AI-driven drug discovery platform and potentially accelerating clinical development. The company's stock rose 1.40% on the news.

Question 11

How did the "Insilico Medicine launches DDD Benchmark as a Service" event impact Insilico Medicine?

Accepted Answer

Insilico Medicine is the developer and provider of the DDD Benchmark, leveraging its proprietary data and validated programs. This launch enhances its reputation as a leader in AI-driven drug discovery and could drive business growth through benchmarking services.

Question 12

How did the "Life Sciences AI Technology Performance Benchmark" event impact Insilico Medicine?

Accepted Answer

Named leader in discovery and preclinical AI, potentially boosting its market credibility.

Question 13

How did the "MacPaw and Liquid AI partnership" event impact Insilico Medicine?

Accepted Answer

Mentioned as an existing customer of Liquid AI, serving as a reference for Liquid AI's capabilities but not directly impacted.

Question 14

How did the "Xi Jinping launches WAICO at WAIC 2026" event impact Insilico Medicine?

Accepted Answer

Founder Alex Zhavoronkov praised Chinese open-source models.

Question 15

How is this data collected?

Accepted Answer

Ergen aggregates thousands of global news sources and extracts structured events, entities, and relationships with sentiment and attention metrics. Pages are daily static snapshots from the platform's live database.